VALENSIN, PIER EGISTO
 Distribuzione geografica
Continente #
NA - Nord America 5.508
EU - Europa 3.587
AS - Asia 2.122
SA - Sud America 370
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 6
Totale 11.733
Nazione #
US - Stati Uniti d'America 5.454
CN - Cina 835
RU - Federazione Russa 711
GB - Regno Unito 632
SG - Singapore 598
IE - Irlanda 533
UA - Ucraina 344
IT - Italia 332
SE - Svezia 301
BR - Brasile 300
FR - Francia 244
DE - Germania 243
VN - Vietnam 196
HK - Hong Kong 175
FI - Finlandia 126
KR - Corea 114
ZA - Sudafrica 65
IN - India 52
ES - Italia 34
CA - Canada 22
BD - Bangladesh 20
MX - Messico 19
NG - Nigeria 19
JP - Giappone 17
IQ - Iraq 16
AR - Argentina 15
EC - Ecuador 15
PL - Polonia 15
NL - Olanda 14
CO - Colombia 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 10
ID - Indonesia 10
TR - Turchia 10
VE - Venezuela 10
BE - Belgio 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
LT - Lituania 7
MA - Marocco 7
SA - Arabia Saudita 7
JO - Giordania 6
PE - Perù 6
AU - Australia 5
CI - Costa d'Avorio 5
KG - Kirghizistan 5
LB - Libano 5
PK - Pakistan 5
CL - Cile 4
HU - Ungheria 4
LU - Lussemburgo 4
PH - Filippine 4
RS - Serbia 4
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SC - Seychelles 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SV - El Salvador 1
Totale 11.705
Città #
Dallas 609
Southend 535
Dublin 527
Fairfield 527
Ashburn 483
Singapore 330
Chandler 316
Jacksonville 271
Santa Clara 258
Woodbridge 252
Menlo Park 235
Moscow 203
San Jose 200
Houston 194
Seattle 185
Cambridge 182
Wilmington 182
Beijing 174
Hong Kong 165
Ann Arbor 148
Milan 147
Council Bluffs 122
Seoul 113
Hefei 112
Princeton 93
Nanjing 92
The Dalles 83
New York 78
Ho Chi Minh City 66
Johannesburg 61
Los Angeles 60
Hanoi 55
Helsinki 55
Munich 54
Lauterbourg 48
Boardman 41
Shanghai 40
Nanchang 34
San Diego 29
Buffalo 27
Rome 27
Columbus 23
London 22
São Paulo 22
San Mateo 20
Venezia 19
Abuja 18
Frankfurt am Main 18
Málaga 18
Hebei 17
Siena 17
Turku 17
Lancaster 16
Redondo Beach 16
Changsha 15
Jiaxing 15
Orem 15
Tianjin 15
Shenyang 14
Figino 13
Washington 12
Brooklyn 11
San Francisco 11
Tokyo 11
Warsaw 11
Bengaluru 10
Chennai 10
Chicago 10
Dearborn 10
Haiphong 10
Kunming 10
Denver 9
Norwalk 9
Tashkent 9
Belo Horizonte 8
Brussels 8
Da Nang 8
Guangzhou 8
Redwood City 8
Rio de Janeiro 8
Toronto 8
Zhengzhou 8
Hangzhou 7
Jinan 7
Phoenix 7
Renton 7
Amman 6
Boston 6
Brno 6
Düsseldorf 6
Florence 6
Guarulhos 6
Porto Alegre 6
Abidjan 5
Bishkek 5
Changchun 5
Dubai 5
Fremont 5
Lanzhou 5
Las Vegas 5
Totale 8.055
Nome #
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 375
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 328
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type 1 nucleoside reverse transcriptase inhibitors 295
A new biomaterial more resistent to infection to be used to manufacture biliary endoprostheses 288
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples 276
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors 271
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy 262
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy 262
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients 258
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 251
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection 247
Helicobacter pylori infection and infertility 243
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 242
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 240
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression 234
Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors 234
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 233
Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy 233
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. 232
Hepatitis C virus infection and myositis: a polymerase chain reaction study 230
Microfilament and microtubule alterations in cultured CHO cells during methyl mercury intoxication and protection with selenite 227
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 224
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA 216
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy 215
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy 214
Synthetic peptides of rubella E1 glycoprotein for serological assays 205
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment 199
NMR investigation of cell cultures: early detection of infection by Herpes simplex virus type 2 and transformation 198
Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype 195
Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1-seropositive individuals 194
Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers 192
Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens 190
Increased reliability of 'selective PCR' using additionally mutated primers and a commercial 'Taq DNA polymerase enhancer' 189
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 187
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 186
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice 186
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells 186
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives 185
Binding properties of monoclonal antibodies to rabies virus 182
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype 182
Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden 177
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction 177
Expression of measles virus antigens in Streptococcus gordonii 167
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 166
Evaluation of the specific immune response after anti-rubella vaccination [Valutazione della risposta immunitaria specifica dopo vaccinazione anti-rosolia] 165
Expression of recombinant E2 and C proteins of rubella virus in insect cells 162
Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma 162
Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction 161
Lack of efficacy of ozone therapy in HIV infection 155
Streptococcus gordonii as a live vaccine vector [Lo Streptococcus gordonii come vettore di vaccini ricombinanti] 153
Low human immunodeficiency virus type 1 (HIV-1)DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR 151
Serological evidence of reinfection among vaccinees during rubella outbreak 147
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis 146
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 143
Viral childhood gastroenteritis 139
Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey 130
Polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in peripheral lymphocytes. Results in subjects with high risk of HIV infection 46
Totale 11.733
Categoria #
all - tutte 35.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022475 0 0 23 46 51 11 35 19 32 79 44 135
2022/20231.085 63 97 148 161 100 230 9 97 89 27 35 29
2023/2024799 21 19 95 46 26 269 264 15 3 4 1 36
2024/20251.441 34 75 126 59 197 86 26 76 129 46 155 432
2025/20263.595 283 477 538 354 656 123 386 145 104 172 53 304
2026/2027469 134 110 225 0 0 0 0 0 0 0 0 0
Totale 11.733